PGNY
What one share of Progyny holds
Services – Misc Health and Allied Services, NEC
Progyny is a global leader in women’s health and family building solutions. We envision a world where everyone can realize their dreams of family and ideal health. Our mission is to empower healthier, supported journeys through transformative fertility, family building and women’s health benefits.
Progyny’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $15.09 |
|---|---|
| Profit | $0.91 |
| Capex (buildings and equipment) | $0.26 |
| Free cash flow | $2.05 |
| Cash and investments | $1.97 |
| Book value | $5.86 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $8.56 | −$2.37 | $0.11 | −$1.78 | — | −$17.19 |
| 2019 | $11.08 | −$0.41 | $0.14 | −$0.22 | — | — |
| 2020 | $3.48 | $0.47 | $0.01 | $0.35 | — | $1.92 |
| 2021 | $4.99 | $0.66 | $0.02 | $0.24 | — | $2.76 |
| 2022 | $7.87 | $0.30 | $0.03 | $0.77 | — | $4.04 |
| 2023 | $10.81 | $0.62 | $0.04 | $1.84 | — | $5.74 |
| 2024 | $12.23 | $0.57 | $0.06 | $1.82 | — | $4.95 |
| 2025 | $14.34 | $0.65 | $0.20 | $2.13 | — | $6.19 |